Global Market for Dental Implants to Reach $5.0 Billion by 2023
October 11, 2018
WELLESLEY, Mass., October 11, 2018 – Rising awareness about the cosmetic and overall health benefits of artificial dental structures are fueling growth of the global market for dental implants. Advents in technology, dental grafting, less invasive procedures and greater deliverability of desired outcomes have also contributed to growth, according to a new report from BCC Research.
In 2018, the global market for dental implants was worth $3.6 billion. BCC Research estimates that it will reach a value of $5.0 billion by 2023, indicating a compound annual growth rate (CAGR) of 6.5%, according to Dental Implants: Global Markets to 2023.
The zirconium segment is anticipated to be the fastest growing product segment over the forecast period. Zirconium functions with nearly the same features as those of titanium, but with higher esthetics and a lesser chance for allergy.
Research Highlights
- Untreated tooth decay is considered to be the most prevalent of the 291 conditions studied between 1990 and 2010 in the international Global Burden of Disease Study.
- Europe dominates the dental implant market, followed by North America. This is due to the majority of the key players in the dental implant industry being situated in Europe.
- The titanium dental implant segment dominated the product market in 2016, owing to the wide use of dental implants made of this material. The biocompatible nature of the pure form of titanium is the main reason for its wide usage in the industry.
“Throughout the forecast period, many non-premium implant companies are expected to capitalize on the growing popularity of discount implants, due to increased price sensitivity that exists on a global scale,” said BCC Research’s staff analyst. “Therefore, premium implant companies, such as Straumann and Nobel Biocare, are expected to face increasing competitive pressure. The market growth of non-premium implants is expected be high in an industry that was so far dominated by premium implant manufacturers.”
Editors/reporters requesting analyst interviews should contact Eric Surber at press@bccresearch.com.
Dental Implants: Global Markets to 2023( HLC218A )
Publish Date: Aug 2018
Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email press@bccresearch.com or visit www.bccresearch.com/media to request access to our library of market research.
BCC Library Membership Benefits
Unlimited Access to Market Research Reports for Academic Institutions and Corporations.
Custom Research
Tailored solutions across industries for your unique business needs.
More in Health Maintenance
- Global Noninvasive Cancer Diagnostics Market to Reach $165.2 Billion by 2030 as Liquid Biopsy, AI-Enabled Screening and Multi-Cancer Detection Tests Transform Oncology
- Long-Term Care and Home Healthcare Technology Market to Reach $64.8 Billion by 2030 as Aging Demographics and Remote Monitoring Reshape Care Delivery
- Thermo Fisher Scientific Inc.: BCC Research Releases Comprehensive 360° Company Analysis
- Healthcare Predictive Analytics Market to Grow at 24.7% CAGR Through 2030
- mHealth Technologies Market Poised for 17.1% CAGR Growth Through 2030
Reports from Health Maintenance
- State of the Life Sciences Industry - 2026 First Quarter Review
- Noninvasive Cancer Diagnostics: Technologies and Global Markets
- Infusion Pumps and Devices: Technologies and Global Markets
- Technologies for Long-Term Care and Home Healthcare: Global Markets
- 3D Protein Structure Analysis: Global Markets
Recent News
- Global Bispecific Antibodies Market to Reach $22.3 Billion by 2030 as Immuno-Oncology Innovation and R&D Investment Accelerate
- Cloud Computing in Cell Biology, Genomics and Drug Development to Reach $15.6 Billion by 2030 as Biological Data Explosion Drives Demand
- Neuroprotective Agents Market to Reach $60.9 Billion by 2030 as Neurological Disease Burden and Aging Populations Drive Pharmaceutical Investment
- Radioligand Therapeutics Market to More Than Double to $4.8 Billion by 2030 as Targeted Cancer Treatments Gain Regulatory Momentum
- Decentralized Clinical Trials Market to Reach $18.8 Billion by 2030 as Digital Health Infrastructure Reshapes Drug Development